🇺🇸 LPV in United States

70 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 23 April 2025 – 23 April 2026
• Total reports: 70

Most-reported reactions

1. Maternal Drugs Affecting Foetus — 20 reports (28.57%)
2. Exposure During Pregnancy — 10 reports (14.29%)
3. Foetal Exposure During Pregnancy — 8 reports (11.43%)
4. Maternal Exposure During Pregnancy — 6 reports (8.57%)
5. Abortion Induced — 5 reports (7.14%)
6. Premature Rupture Of Membranes — 5 reports (7.14%)
7. Abortion Spontaneous — 4 reports (5.71%)
8. Congenital Anomaly — 4 reports (5.71%)
9. Neural Tube Defect — 4 reports (5.71%)
10. Plagiocephaly — 4 reports (5.71%)

Source database →

Frequently asked questions

Is LPV approved in United States?

LPV does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for LPV in United States?

Bristol-Myers Squibb is the originator. The local marketing authorisation holder may differ — check the official source linked above.